NewAmsterdam Pharma Co N.V.

NAMS · NAMSW · Pharmaceutical Preparations

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • NAMS · N62509109 - Ordinary Shares, nominal value EUR0.12 per share
  • NAMSW · N62509117 - *W EXP 99/99/999
Company details and SEC sources

CIK 0001936258 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
NAMS, NAMSW on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Pharmaceutical Preparations (Office of Life Sciences)
Business address
Gooimeer 2 35, Narrden, Netherlands, 1411 DC
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
Netherlands
Fiscal year end
31 December
Former names on EDGAR
NewAmsterdam Pharma Co B.V. (to 22 Nov 2022)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .